Polyvinylidene Fluoride (PVDF) Syringe Filters - SF18052
Biopharmaceutical and cell culture laboratories demand ultrafiltration technology capable of removing mycoplasma contamination from aqueous biological samples while maintaining rapid flow characteristics and low protein binding essential for therapeutic protein manufacturing and critical sterile processing applications. Advanced hydrophilic polyvinylidene fluoride membrane technology with 0.1 µm pore size delivers mycoplasma removal capability through ultrafine filtration performance that exceeds conventional sterile-grade specifications while eliminating pre-wetting requirements for immediate aqueous sample processing. Furthermore, the 33mm diameter configuration with 4.9 cm² filtration area enables efficient sterilization of volumes exceeding 100 ml, making this design ideal for biopharmaceutical manufacturing and bioprocessing workflows requiring submicron contamination control beyond standard bacterial retention capabilities.
Key Hydrophilic PVDF Membrane Characteristics
- Naturally wettable surface eliminates alcohol pre-wetting steps for aqueous processing, enabling immediate filtration of biological samples without preparatory procedures
- 0.1 µm pore size removes mycoplasma and submicron particles, providing critical contamination control for cell culture media and pharmaceutical formulations requiring ultrafine filtration
- Low protein binding affinity maintains the concentration of therapeutic proteins and enzymes during ultrafiltration, minimizing product loss in biopharmaceutical development applications
- Chemical compatibility resists degradation from biological buffers and mild acids while maintaining stable operation across pharmaceutical manufacturing environments
- Sterile packaging eliminates contamination risks for aseptic processing, supporting GMP manufacturing requirements in pharmaceutical production facilities
Key Construction Characteristics
- 100 µL holdup volume minimizes loss of valuable pharmaceutical compounds and biological materials, optimizing yield for high-volume sterile processing applications
- Polypropylene housing delivers structural integrity to 87 psi maximum operating pressure with thermal stability to 60°C for diverse bioprocessing conditions
- Dual Luer-Lok and Luer-Slip connections accommodate standard syringes without adapters, streamlining aseptic transfer procedures in pharmaceutical manufacturing workflows
- Integrated polypropylene prefilter extends membrane lifetime by capturing larger particulates upstream, reducing filter consumption in cell culture applications
Pharmaceutical and biotechnology laboratories processing high-volume biological samples require ultrafiltration technology that combines mycoplasma removal with rapid throughput and minimal protein loss. Hydrophilic PVDF syringe filters deliver 0.1 µm sterile-grade performance through naturally wettable membrane chemistry and integrated prefilter design. Optimized for your challenging biopharmaceutical workflows, this filtration solution provides workflow efficiency with validated mycoplasma retention, sterile packaging for aseptic processing, and low protein binding for pharmaceutical manufacturing, cell culture sterilization, and quality control applications requiring submicron particle removal beyond conventional bacterial retention specifications.
For more information about chemical and material compatibility, please review our Chemical Compatibility Chart.
- Bubble Point (psi)
- 26.1psi
- Connection Type
- Luer-Lok/ Luer Slip
- Diameter
- 33mm
- Filtration Area
- 4.9cm²
- Flow Rate
- 12ml
- Holdup Volume
- 100μL
- Material
- Polyvinylidene Fluoride (PVDF)
- Maximum Operating Pressure
- 87psi
- Maximum Operating Temperature (°C)
- 60°C
- Membrane Thickness (µm)
- 100-130μm
- Pack Count
- 100
- Pore Size (µm)
- 0.1
- Prefilter (Yes/No)
- Yes
- Prefilter Material
- PP
- Sterility
- Sterile
- Volume Throughput (ml)
- 110ml
- Wetability
- Hydrophilic
- Mycoplasma Removal - Eliminates mycoplasma contamination from cell culture media and serum supplements for biopharmaceutical manufacturing and research
- Cell Culture Media Sterilization - Provides ultrafine filtration for aqueous growth media requiring submicron contamination control in bioprocessing facilities
- Therapeutic Protein Processing - Filters biological formulations requiring mycoplasma removal while preserving protein concentration and activity
- Vaccine Production - Sterilizes aqueous vaccine formulations and biological buffers for pharmaceutical manufacturing requiring submicron particle control
- Serum and Supplement Filtration - Processes biological additives for cell culture applications requiring mycoplasma elimination and sterile conditions
- Biotechnology QC Testing - Prepares samples for mycoplasma testing and contamination analysis in pharmaceutical quality control laboratories